During the past decade, Prevention Point Philadelphia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prevention Point Philadelphia" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Prevention Point Philadelphia" are "HIV Infections" (1 trials), "HIV/AIDS" (1 trials), "Opioid Overdose" (1 trials), "Opioid Use" (1 trials) and "Opioid-use Disorder" (1 trials). Many other conditions were trialed in "Prevention Point Philadelphia" in a lesser frequency.

Most popular intervention types in "Prevention Point Philadelphia" are "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Basic Intervention" (1 trials), "Contingency Management" (1 trials), "Enhanced Intervention" (1 trials), "Expressive Writing" (1 trials) and "Interview" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prevention Point Philadelphia" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Prevention Point Philadelphia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Prevention Point Philadelphia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prevention Point Philadelphia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".